Our experimental findings demonstrate that AP-02 inhibits cancer cell proliferation through G0/G1 cell cycle arrest (< 5 μM, low dose) in addition to apoptosis induction (high dose) in wild-type p53 colon cancer (COLO 205) cells, both in cultured cells and in xenograft animals. This evidence concerns the gene TP53 and colonic neoplasm.